$9 Billion Verdict for Actos Cancer Victims
January 24th, 2017|
The diabetes drug Actos belongs to a class of medication called thiazolidinediones. These drugs were initially designed to treat the symptoms of Type 2 diabetes, and have since been prescribed to hundreds of thousands of people around the world. Although Actos and other medications in this drug class are effective in treating Type 2 diabetes, they’ve also been known to cause serious health complications to users, including an increased risk of developing bladder cancer or suffering heart failure.
In 2011, the FDA released a warning that linked the prolonged use of Actos to an increased risk of bladder cancer. That announcement also included a mandate for stronger warning label language to be used on Actos packaging. Despite the FDA warning, more and more patients were prescribed the drug, increasing the number of people at risk and resulting in a 2014 verdict ordering Takeda Pharmaceutical Company Limited and Eli Lilly & Company to pay $9 billion in punitive damages for concealing these risks.
If you’ve suffered health complications after taking the diabetes drug Actos, you may be entitled to a substantial cash award from the drug manufacturer. Call our experienced drug injury lawyers today for a free evaluation of your claim. You deserve to be compensated for what you’ve been through, and we’re ready to fight for the money you deserve. Contact us today.